[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100594387":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":21,"responsibleParty":37,"collaborators":10,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":10,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":10,"studyType":52,"phases":10,"briefSummary":53,"conditions":54,"keywords":10,"overallStatus":56,"whyStopped":10,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"Kerckhoff Klinik","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"CCS patients",null,"Clinical patients referred for ischaemia testing (CMR\u002Fcoronary angiogram) will undergo the respective counterpart as well so that patients will have undergone both CMR and invasive testing.",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Sören Jan Backhaus, MD","CONTACT","06032-996-2620","s.backhaus@kerckhoff-klinik.de",{"name":19,"role":15,"phone":16,"phoneExt":10,"email":20},"Andreas Rolf, MD","a.rolf@kerckhoff-klinik.de",[22],{"facility":5,"status":10,"city":23,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Bad Nauheim","Hesse","61231","Germany","DE",{"type":29,"coordinates":30},"Point",[31,32],8.73859,50.36463,{"lat":32,"lon":31},[35],{"name":36,"role":15,"phone":10,"phoneExt":10,"email":10},"Markus Schönburg",{"type":38,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100594387","cmr-derived-quantitative-perfusion-for-prediction-of-ffr-100594387",false,"NCT07018778","CMR-derived Quantitative Perfusion for Prediction of FFR","Quantification of Myocardial Blood Flow in Cardiovascular Magnetic Resonance for Prediction of Fractional Flow Reserve in Coronary Catheterisation","Inclusion Criteria:\n\n* clinical indication for vasodilatator CMR or invasive coronar angiography\n* capability to give informed consent\n\nExclusion Criteria:\n\n* general: non-compliance, \\\u003C18 years of age, pregnancy\n* contraindications for CMR (non-CMR compatible device, chronic kidney disease (eGFR \\\u003C30ml\u002Fmin), allergies (medications)","ALL","18 Years","99 Years",{"count":50,"type":51},200,"ESTIMATED","OBSERVATIONAL","Patients will undergo quantitative perfusion assessment in cardiovascular magnetic resonance imaging (dual bolus or dual sequence approach) as well as invasive coronary angiography for assessment of fractional flow reserve (FFR) including assessment of coronary flow reserve (CFR) and microcirculatory resistance (IMR).",[55],"Chronic Coronary Syndrome","NOT_YET_RECRUITING","2025-06-13",{"date":59,"type":60},"2025-06-18","ACTUAL",{"date":62,"type":51},"2025-07-01",{"date":64,"type":51},"2026-09-30",{"name":5,"class":6},1]